Trials / Completed
CompletedNCT01725776
Inhaled Milrinone in Cardiac Surgery
Pharmacokinetic and Pharmacodynamic of Inhaled Milrinone in Cardiac Surgical Patients
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Montreal Heart Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the concentration-effect relationship of inhaled milrinone after prophylactic administration in cardiac surgical patients with preoperative pulmonary hypertension undergoing cardiopulmonary bypass.
Detailed description
Milrinone elimination will be verify with blood and urine samples analysis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Inhaled milrinone 5 mg | Inhaled milrinone 5 mg (as for the injectable solution) |
Timeline
- Start date
- 2006-12-01
- Primary completion
- 2012-02-01
- Completion
- 2012-06-01
- First posted
- 2012-11-14
- Last updated
- 2012-11-14
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01725776. Inclusion in this directory is not an endorsement.